News

February 4, 2009 – Hospitals are increasingly looking at interoperability between systems as they move to digital imaging and purchase systems from different vendors, according to a new report from Kalorama Information titled "Medical Imaging Markets, Volume I: Radiography (X-Ray, Digital X-Ray, Fluoroscopy, Mammography, and CT Markets)."

Home February 04, 2009
Home
News

February 4, 2009 - Heart Imaging Technologies (HeartIT) said it has created the first free Web site allowing patients to upload and share diagnostic-quality medical images using nothing but a standard Web browser. The URL is www.webpax.com.

Home February 04, 2009
Home
News

February 3, 2009 - New research proves increased QT variability is an independent predictor of ventricular tachycardia (VT) or ventricular fibrillation (VF) in men, while in women, QT variability alone does not pose a risk of arrhythmic events.

Home February 04, 2009
Home
News

February 4, 2009 - Arizona Heart Institute will present the 22nd Annual Public Forum showcasing a live-telecast of the latest surgical treatments for heart and blood vessel disease on Tuesday, Feb. 10, 2009.

Home February 04, 2009
Home
News

February 4, 2009 - The Medical Imaging & Technology Alliance (MITA) responds that the study by Jörg Hausleiter, M.D., in the Feb. 4 issue of the Journal of the American Medical Association (JAMA) correctly focuses on what providers need to know to ensure that computed tomography angiography (CTA) is utilized appropriately.

Home February 04, 2009
Home
News

February 4, 2009 - In recent years, cardiac computed tomography angiography (CTA) has emerged as a useful diagnostic imaging modality for the assessment of coronary artery disease (CAD), and new research shows there are significantly lower doses of radiation associated with cardiac CTA than have been previously reported in several earlier studies.

Home February 04, 2009
Home
News

February 4, 2009 - According to a new market research report released this month by market research firm IMV Medical Information Division, the adoption of 64-slice CT equipment by cardiology practices throughout the U.S. has more than doubled over the past two years.

Home February 04, 2009
Home
News

February 4, 2009 - On Thursday, Feb. 19 at 7:00 pm, The Halifax Health - Center for Cardiology, Daytona Beach, FL will present a live online panel discussion on an automated implantable cardiac defibrillator (ICD) surgical case.

Home February 03, 2009
Home
News

February 3, 2009 - Bioheart Inc. has arranged with its Italian partner, Biomedica, for a complete grant-supported study of the Bioheart A&C Bio Science T-PLS Twin-Pulsatile Life Support System.

Home February 03, 2009
Home
News

February 3, 2009 – Medtronic has completed enrollment in PROTECT, the company’s global study comparing its Endeavor drug-eluting stent (DES) to Johnson & Johnson’s Cypher DES.

Home February 03, 2009
Home
News

February 2, 2009 - Boston Scientific Corp. today said it began patient enrollment in the PLATINUM clinical trial, which is designed to evaluate the company’s PROMUS Element Everolimus-Eluting Coronary Stent.

Home February 03, 2009
Home
News

February 2, 2009 - Cardiac Dimensions Inc. today said it received the CE Mark approval for its CARILLON Mitral Contour System from KEMA Quality B.V., a European Union Notified Body from the Netherlands.

Home February 03, 2009
Home
News

February 2, 2009 - CardiArc, Inc., along with Clinical Engineering Consultants Inc. (CEC) of Erlanger, KY, today said CEC will provide field service for the CardiArc HD-SPECT system. CEC also brings technical consultation with CardiArc on the field service manual. In addition CEC will sell the CardiArc system in the Ohio River Valley area.

Home February 03, 2009
Home
Technology

February 3, 2009 - The FDA has granted Pathway Medical Technologies Inc., 510(k) clearance to market its newest peripheral atherectomy catheter, the Jetstream G2, for use in the treatment of peripheral artery disease (PAD) in the lower limbs.

Home February 03, 2009
Home
News

February 3, 2009 - Cerenis Therapeutics SA, a privately held pharmaceutical company developing HDL-related compounds for the treatment of cardiovascular and metabolic diseases, has in-licensed intellectual property supporting an investigational new treatment of aortic valve stenosis (AVS) based on HDL therapy.

Home February 03, 2009
Home
Subscribe Now